Sildenafil Tablet, Film Coated
Product Images NDC 65862-690

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 65862-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sildenafil Fig1)

FDA Label Image

Package Label-principal Display Panel (100 mg (30Tablets Bottle))

This is a description of Sildenafil tablets manufactured by Aurobindo Pharma USA Inc. Each film-coated tablet contains 100mg of Sildenafil citrate USP. The usual dosage should be determined by a healthcare professional. The tablets should be stored at a controlled room temperature between 20°C to 25°C. Dispensing should be in tight containers as per USP guidelines. The batch number and expiry date will be printed during coding. The product is made in India.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

This is a graph comparing the change in systolic blood pressure (SBP) over time postdose (in hours) for two groups: one receiving Doxazosin + Placebo medication and the other one receiving Doxasin + Sildenafil 25 mg medication. The x-axis represents time postdose (in hours) and the y-axis represents the mean standing SBP change from baseline (in mmHg). The SBP values for the Doxasin + Sildenafil 25 mg are generally lower than those for Doxazosin + Placebo.*

FDA Label Image

Figure 3 (Sildenafil Fig3)

FDA Label Image

Figure 4 (Sildenafil Fig4)

FDA Label Image

Figure 5 (Sildenafil Fig5)

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

The text describes a figure displaying the effect of Sildenafil and Placebo on erection maintenance by baseline score. The figure shows different percentages of patients at endpoint, categorized by baseline score. It is not possible to interpret the data without the visual aid.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

FDA Label Image

Package Label-principal Display Panel (25 mg (30 Tablets Bottle))

This is a description of Sildenafil, a medication used to treat erectile dysfunction. The tablets come in a film-coated form, with each tablet containing Sildenafil Citrate USP equivalent to sildenafil 25 mg. Aurobindo Pharma USA, Inc. distributes this medication, which is made in India. The usual dosage is specified in the accompanying prescribing information. The medication should be stored at 20° to 25°C (68° to 77°F) in tight containers. The batch and expiry dates of the medication will be printed during coding.*

FDA Label Image

Package Label-principal Display Panel (50 mg (30 Tablets Bottle))

This is a medication with the NDC code 65862-690-30. Each tablet contains 50mg of Sildenafil citrate. The usual dosage information is not available and consumers should refer to the accompanying Rxonly prescribing information. The medication should be stored in a tight container in a controlled room at a temperature of 20° to 25°C (68° to 77°F). The details of batch and expiry will be printed during coding. It is distributed by Aurobindo Pharma USA, Inc. and made in India. There is a coding area and dotted lines that are not meant to print around it.*

FDA Label Image

Structure (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.